The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Oct. 05, 2021
Filed:
Sep. 20, 2017
Applicant:
Dana-farber Cancer Institute, Inc., Boston, MA (US);
Inventors:
Sara Buhrlage, Somerville, MA (US);
Ellen Weisberg, Chelmsford, MA (US);
James D. Griffin, Brookline, MA (US);
Assignee:
Dana-Farber Cancer Institute, Inc., Boston, MA (US);
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61P 31/00 (2006.01); C07K 16/30 (2006.01); A61P 35/02 (2006.01); C12Q 1/6886 (2018.01); G01N 33/50 (2006.01); G01N 33/574 (2006.01); A01K 67/027 (2006.01); C12Q 1/02 (2006.01); C12Q 1/6806 (2018.01); C12Q 1/6841 (2018.01); C12Q 1/6851 (2018.01); C12Q 1/686 (2018.01); A61K 45/06 (2006.01);
U.S. Cl.
CPC ...
C07K 16/3061 (2013.01); A01K 67/0271 (2013.01); A61P 31/00 (2018.01); A61P 35/02 (2018.01); C12Q 1/025 (2013.01); C12Q 1/6806 (2013.01); C12Q 1/686 (2013.01); C12Q 1/6841 (2013.01); C12Q 1/6851 (2013.01); C12Q 1/6886 (2013.01); G01N 33/50 (2013.01); G01N 33/57426 (2013.01); A01K 2267/0331 (2013.01); A61K 45/06 (2013.01); C12Q 2600/106 (2013.01); C12Q 2600/158 (2013.01); G01N 2800/52 (2013.01);
Abstract
The present invention is based, in part, on the identification of novel USP10 biomarkers and modulators, and methods of use thereof, for identifying, assessing, preventing, and treating AML.